Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2003003976A3 Compositions for removing human cerumen
05/30/2003WO2003002106A3 Use of tyrosine kinase inhibitions for treating allergic diseases
05/30/2003WO2002102360A3 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002094187A3 Novel use
05/30/2003WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
05/30/2003WO2002086504A3 Individualization of therapy with gastroesophageal reflux disease agents
05/30/2003WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery
05/30/2003WO2002078698A3 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064214A3 Anti cancer combination of substituted pyrroles and paclitaxel
05/30/2003WO2002064132A3 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
05/30/2003WO2002062795A3 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
05/30/2003WO2002055490A3 Metabolic controlled fermentation process for carbamoyl tobramycin production
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002051415B1 Use of sequestrants for treating prion diseases
05/30/2003WO2002042284A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
05/30/2003WO2002041897A3 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same
05/30/2003WO2002041871A9 Composition comprising an imexon or derivatives thereof and lipids
05/30/2003WO2002041827A9 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
05/30/2003WO2002036148A3 Use of death receptor ligands or rip to initiate the non-caspase-dependent cell death and compounds for inhibition of the non-caspase-dependent cell death
05/30/2003WO2002036116A9 Tripeptidyl peptidase inhibitors
05/30/2003WO2002036109A3 Use of pyridoxamine for the treatment and inhibition of obesity-related complications
05/30/2003WO2002034244A3 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
05/30/2003WO2002020090A3 Pharmaceutical compositions
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity
05/30/2003WO2001080823A3 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
05/30/2003WO2001052874A9 Intra-tumoral administration of il-12 encoding nucleic acid molecules
05/30/2003CA2741542A1 Processed baby food with unsaturated fatty acids and/or nucleotides
05/30/2003CA2506616A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
05/30/2003CA2503669A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
05/30/2003CA2468170A1 Method for identification of tumor targeting enzymes
05/30/2003CA2468046A1 Novel tetronic acid derivative
05/30/2003CA2468018A1 Micronized film-forming powder comprising an active substance
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467926A1 Biologically active complex
05/30/2003CA2467915A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/30/2003CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
05/30/2003CA2467827A1 Methods and reagents for the control of infestations of parasites
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467749A1 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003CA2467729A1 Functional acylglycerides
05/30/2003CA2467652A1 Reversible proton pump inhibitors for the treatment of airway disorders
05/30/2003CA2467559A1 Topical delivery of codrugs
05/30/2003CA2467551A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003CA2467549A1 Use of an ascomycin for the treatment of blepharitis
05/30/2003CA2467542A1 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
05/30/2003CA2467536A1 The use of leptin in fertility
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467240A1 Xanthine oxidase inhibition
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467166A1 New pharmaceutical compounds
05/30/2003CA2467104A1 A plant extract active as an immunostimulating agent
05/30/2003CA2467095A1 Hypertonia treatment during the acute phase of a cerebrovascular accident
05/30/2003CA2467035A1 Pharmaceutical product with an adsorbent
05/30/2003CA2466986A1 Pharmaceutical formulation comprising bicalutamide
05/30/2003CA2466982A1 Pharmaceutical compositions in particulate form
05/30/2003CA2466927A1 Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466916A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/30/2003CA2465807A1 Use of bisindolmaleimide and gemcitabine for the treatment of cancer
05/30/2003CA2465779A1 Compositions for sustained action product delivery
05/30/2003CA2464867A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2429539A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
05/30/2003CA2413224A1 Aqueous solution of ascorbic acid and method for producing same
05/30/2003CA2407302A1 Genes transfection into bony tissues
05/29/2003US20030101466 Method for screening for agents against cancer using an immunosuppression animal model
05/29/2003US20030100772 Oxygen-containing heterocyclic compounds
05/29/2003US20030100771 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or s2-keto-l-gulonate esters
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100769 Such s 2-(6-chloro-3-pyridyl)-2-imidazoline which has good affinity for and activate alpha-4-beta-2-nicotinic acetyl-choline receptors; for treatment and prevention of neuro-degenerative disorders (Alzheimer's/Parkinson's disease)
05/29/2003US20030100765 Process for preparing heterocyclo-alkysulfonyl pyrazole derivatives
05/29/2003US20030100764 Thioether substituted imidazoquinolines
05/29/2003US20030100759 Selective anti-viral nucleoside chain terminators
05/29/2003US20030100756 Treatment of acute or chronic inflammatory diseases
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100750 Process for solid supported synthesis of pyruvate-derived compounds
05/29/2003US20030100742 Erythromycin a derivatives
05/29/2003US20030100616 Administering to a patient for the treatment and/or prophylaxis an effective amount of 3-amino-propoxy derivative as a potent, beta-1-sepcific beta blocker whith a short duration of action in the systemic circulation
05/29/2003US20030100615 Antineoplastic polyamines capable of uptake by a target cell upon administration to a human or non-human animal, and upon uptake bind via an electrostatic interaction between positively charged nitrogen and biological counter- anions
05/29/2003US20030100614 Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of chlamydia pneumoniae infections
05/29/2003US20030100612 Aqueous solution of arginine and ibuprofen for the treatment of pain, inflammation and fever
05/29/2003US20030100611 Delivery of gabapentin in a gastric retained dosage form for the treatment of epilepsy and other diseases
05/29/2003US20030100610 Omega -3 series polyunsaturated fatty acids are selected from eicosapentanoic acid and/or docosahexaenoic acid and/or pharmaceutically acceptable derivative
05/29/2003US20030100609 Orally ingesting a quantity of calcium formate sufficient to improve calcium balance or retention
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
1 ... 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 ... 7860